Denmark mentioned Monday it is going to bar the Johnson & Johnson vaccine from its Covid inoculation drive over worries about blood clots, following an analogous transfer in opposition to the AstraZeneca jab.
The Danish Health Authority famous that the European Medicines Agency (EMA) “has concluded that there is a possible link between rare but severe cases of blood clots” and the Johnson & Johnson drug.
Both the EMA and the World Health Organization have nevertheless recommmended using the Johnson & Johnson vaccine on the idea that the advantages outweigh the dangers.
But Danish well being officers mentioned the present beneficial epidemiological state of affairs within the Scandinavian nation meant it may do with out the J&J jab, and would rely solely on the Pfizer/BioNTech and Moderna vaccines.
“The Danish Health Authority has concluded that the benefits of using the Covid-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect… in those who receive the vaccine,” the authority mentioned in an announcement.
“Therefore, the Danish Health Authority will continue the Danish mass vaccination programme against Covid-19 without the Covid-19 vaccine from Johnson & Johnson,” it added.
The well being authority famous Denmark’s epidemic was presently “under control,” and that “the vaccination rollout is progressing satisfactorily with other available vaccines.”
But it acknowledged that the choice would delay the vaccination marketing campaign.
In mid-April, Denmark introduced it was chopping the AstraZeneca vaccine from its vaccination marketing campaign after placing it on maintain a month earlier, citing comparable issues, turning into the primary nation in Europe to fully reduce the vaccine.
Denmark has mentioned it may re-evaluate using each vaccines ought to the state of affairs change.
“New knowledge may emerge, or the situation in Denmark may change, for example, in terms of infection pressure, disease burden, epidemic control, or other vaccines’ availability,” the well being authority mentioned.
Of Denmark’s 5.eight million inhabitants, 11.5 % are totally vaccinated and 23.four % have acquired a primary dose of the vaccine.
Currently there are 4 vaccines authorised to be used within the EU: Pfizer-BioNTech, Moderna, AstraZeneca and Johnson & Johnson — the latter two reserved for older folks in most European nations.
In April, the US quickly suspended using the Johnson & Johnson vaccine after it was linked to uncommon circumstances of thrombosis.
(Except for the headline, this story has not been edited by StayNews360 employees and is printed from a syndicated feed.)